Pathophysiology and Therapy of Neuropathic Pain
A special issue of Life (ISSN 2075-1729). This special issue belongs to the section "Physiology and Pathology".
Deadline for manuscript submissions: closed (28 June 2024) | Viewed by 2441
Special Issue Editors
Interests: neuropathic pain; neuralgia; mechanical ventilation; ARDS; respiratory failure; perioperative medicine; sugammadex; delirium; COVID-19; quantum medicine; biophysics; dexmedetomidine; dexamethasone; ketamine
Interests: lung protective ventilation; neuropathy; muscle relaxants; mechanical ventilation; ARDS; respiratory failure; perioperative medicine; sugammadex; delirium, electrical impedance tomography; xenon; dexmedetomidine; dexamethasone; ketamine
Special Issue Information
Dear Colleagues,
Neuropathic pain arises from damage or disease affecting the somatosensory nervous system. It is a common and debilitating symptom that significantly reduces quality of life, and is often inadequately treated. The pain presents in different forms, including persistent or intermittent sensations of burning, pricking, or squeezing, and can be evoked by a light touch or being cold. The mechanisms underlying neuropathic pain are diverse, involving ectopic nerve activity, compressed nerves or roots, dorsal root ganglia and thalamus, signals spreading to adjacent areas, and peripheral and central sensitization. Sensitization may be caused by structural changes, cell–cell interactions, and molecular signaling alterations, such as ion channel modifications, immune cell activation, glial-mediated processes, and epigenetic regulation.
Various conditions contribute to the onset of neuropathic pain, including metabolic disorders, viral infections, autoimmune disorders, chemotherapy-induced neuropathies, trauma, inflammatory disorders, hereditary neuropathies, and channelopathies. Efforts have been made to enhance therapeutic options for neuropathic pain, utilizing gabapentinoids, tricyclic antidepressants, selective serotonin–norepinephrine reuptake inhibitors, lidocaine, capsaicin, tramadol, and botulinum toxin.
Despite advances in understanding these mechanisms and therapies, neuropathic pain remains challenging to comprehend and treat, representing an unmet medical need. The pathophysiology is highly diverse, with numerous molecular mechanisms being involved. Although scientific knowledge is expanding, treatment options have not seen significantly improved, indicating a gap in our understanding of neuropathic pain. Exciting fields of research are emerging, unraveling underlying neural circuits and providing critical insights into new pharmacological and biophysical strategies. Overcoming obstacles in developing targeted therapies and addressing translation challenges between animal and human studies remain goals to be achieved.
We cordially invite you and your colleagues to contribute original research articles and reviews focusing on neuropathic pain's clinical presentation, physiological mechanisms, treatment, prognosis, and prevention. By comprehending the links between neurochemical, inflammatory, and structural mechanisms and specific clinical presentations of neuropathic pain, we can improve rational pain management and significantly advance our understanding of this critical phenomenon.
Dr. Aiman Suleiman
Dr. Maximilian Sebastian Schaefer
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Life is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- neuron
- neuropathic pain
- neuralgia
- nerve damage
- neuropathy
- neural circuit
- nervous system
- sensitization
- channelopathy
- pain
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue policies can be found here.
